G Chokkalingam, Founder & MD at Equinomics Research & Advisory told CNBC-TV18, "We advised our clients not to apply to ICICI Prudential Life Insurance Company because we have found that it is quite stretched in terms of valuations. So, even after weak opening, I would still suggest hold and wait for anywhere below Rs 300." "If you see the last four years, its net profit has grown at around 5 percent per annum and the premium also has grown in single digit at around 8 percent. Going forward, the competition is going to be very tough because we have seen the consolidation, we have seen the infusion of FDI into the insurance sector and third the whole economy has slowed down, so therefore the insurance business also has slowed down. So, therefore I would be comfortable to look at the stock anywhere around Rs 280-285 levels," he added
Thursday, 29 September 2016
Home »
» Look at ICICI Prudential at around Rs 280-285-:- Equity Research
Look at ICICI Prudential at around Rs 280-285-:- Equity Research
03:54
Related Posts:
Essar Power Gujarat posts Rs 1 cr net profit in June quarter-:- Equity Research Ruias-owned Essar Power Gujarat Ltd (EPGL) today posted Rs 1 crore net profit in the first quarter of this fiscal due to improved efficiency. "Finance costs for first quarter of 2016-17 were lower by 12 per… Read More
3 academicians named as Monetary Policy Committee members-:- Equity Research The Appointments Committee of the Cabinet today announced the names of Monetary Policy Committee members, who will hold office for a period of four years. This includes Chetan Ghate, Associate professor - Economics & P… Read More
Den Networks pref issue to fund broadband expansion, pare debt-:- Equity Research Den Networks ’ board on Tuesday approved preferential allotment of 1.58 crore shares at Rs 90 per share to Goldman Sachs. Sharing details of the issue with CNBC-TV18 CFO Manish Dawar said this will increase … Read More
Coal India arm seeks green nod for Rs 10,000 cr power plant-:- Equity Research Going ahead with its plan of setting up of around Rs 10,000 crore power plant in Odisha, Coal India arm Mahanadi Coalfields has approached the environment ministry to seek green clearance for the 1,600 mw coal-based thermal… Read More
USFDA bans products from Laxachem Organics-:- Equity Research The US health regulator has banned products from Maharashtra-based bulk drug maker Laxachem Organics for refusing inspection of its plant. The US Food and Drug Administration (USFDA) has placed Laxachem Organics Pvt Ltd on … Read More
0 comments:
Post a Comment